| Date Filed | Type | Description |
| 08/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 04/28/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/10/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/10/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/11/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/10/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 01/24/2022 |
4
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (10% Owner) has filed a Form 4 on NATURES SUNSHINE PRODUCTS INC|
Txns:
| Acquired 711 shares
@ $0
Acquired 9,558 shares
@ $0
Acquired 25,000 shares
@ $8.72, valued at
$218k
|
|
| 11/12/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/12/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/11/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/05/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/12/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/12/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/11/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 12/13/2019 |
4
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (10% Owner) has filed a Form 4 on NATURES SUNSHINE PRODUCTS INC|
Txns:
| Acquired 14,125 shares
@ $0
Acquired 25,000 shares
@ $7.8, valued at
$195k
|
|
| 11/12/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/12/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/10/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 01/31/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 12/06/2018 |
4
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (10% Owner) has filed a Form 4 on CONTRAFECT Corp|
Txns:
| Sold 600,000 shares
@ $2.04, valued at
$1.2M
|
|
| 12/06/2018 |
3/A
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (10% Owner) has filed a Form 3/A on CONTRAFECT Corp |
| 11/09/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/13/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/08/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/09/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/07/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/31/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/18/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/20/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |